Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Org Chem ; 85(13): 8339-8351, 2020 07 02.
Article in English | MEDLINE | ID: mdl-32462862

ABSTRACT

An efficient general methodology for the synthesis of 4-quinolinyl ethers is demonstrated via a highly reactive SNAr reaction of 4-quinolinyl sulfones with a range of structurally diversified 1°, 2°, and 3° alcohols with a wide substrate scope and high yields. By adapting this methodology, a convergent synthesis of a complex target of HCV NS3/4a protease inhibitor BI 201420 was accomplished.


Subject(s)
Hepatitis C , Viral Nonstructural Proteins , Antiviral Agents , Ethers , Hepacivirus , Humans , Protease Inhibitors/pharmacology , Sulfones
2.
J Org Chem ; 83(3): 1448-1461, 2018 02 02.
Article in English | MEDLINE | ID: mdl-29323903

ABSTRACT

A chromatography-free, asymmetric synthesis of the C2-symmetric P-chiral diphosphine t-Bu-SMS-Phos was developed using a chiral auxiliary-based approach in five steps from the chiral auxiliary in 36% overall yield. Separtion and recovery of the auxiliary were achieved with good yield (97%) to enable recycling of the chiral auxiliary. An air-stable crystalline form of the final ligand was identified to enable isolation of the final ligand by crystallization to avoid chromatography. This synthetic route was applied to prepare up to 4 kg of the final ligand. The utility of this material was demonstrated in the asymmetric hydrogenation of trifluoromethyl vinyl acetate at 0.1 mol % Rh loading to access a surrogate for the pharmaceutically relavent chiral trifluoroisopropanol fragment in excellent yield and enantiomeric excess (98.6%).

3.
Org Lett ; 16(16): 4090-3, 2014 Aug 15.
Article in English | MEDLINE | ID: mdl-25061799

ABSTRACT

An efficient production synthesis of the SGLT-2 inhibitor Empagliflozin (5) from acid 1 is described. The key tactical stage involves I/Mg exchange of aryl iodide 2 followed by addition to glucono lactone 3 in THF. Subsequent in situ treatment of the resulting lactol with HCl in MeOH produces ß-anomeric methyl glycopyranoside 4 which is, without isolation, directly reduced with Et3SiH mediated by AlCl3 as a Lewis acid in CH2Cl2/MeCN to afford 5 in 50% overall yield. The process was implemented for production on a metric ton scale for commercial launch.


Subject(s)
Aluminum Compounds/chemistry , Benzhydryl Compounds/chemical synthesis , Benzhydryl Compounds/pharmacology , Chlorides/chemistry , Glucosides/chemical synthesis , Glucosides/pharmacology , Hypoglycemic Agents/chemical synthesis , Hypoglycemic Agents/pharmacology , Silanes/chemistry , Sodium-Glucose Transporter 2 Inhibitors , Aluminum Chloride , Benzhydryl Compounds/chemistry , Glucosides/chemistry , Hypoglycemic Agents/chemistry , Molecular Structure , Oxidation-Reduction
4.
J Org Chem ; 78(8): 3616-35, 2013 Apr 19.
Article in English | MEDLINE | ID: mdl-23544738

ABSTRACT

The development of a large scale synthesis of the glucocorticoid agonist BI 653048 BS H3PO4 (1·H3PO4) is presented. A key trifluoromethyl ketone intermediate 22 containing an N-(4-methoxyphenyl)ethyl amide was prepared by an enolization/bromine-magnesium exchange/electrophile trapping reaction. A nonselective propargylation of trifluoromethyl ketone 22 gave the desired diastereomer in 32% yield and with dr = 98:2 from a 1:1 diastereomeric mixture after crystallization. Subsequently, an asymmetric propargylation was developed which provided the desired diastereomer in 4:1 diastereoselectivity and 75% yield with dr = 99:1 after crystallization. The azaindole moiety was efficiently installed by a one-pot cross coupling/indolization reaction. An efficient deprotection of the 4-methoxyphenethyl group was developed using H3PO4/anisole to produce the anisole solvate of the API in high yield and purity. The final form, a phosphoric acid cocrystal, was produced in high yield and purity and with consistent control of particle size.


Subject(s)
Amides/chemistry , Benzamides/chemistry , Glucocorticoids/agonists , Glucocorticoids/chemistry , Pyridines/chemistry , Pyrroles/chemistry , Molecular Structure , Stereoisomerism
5.
J Org Chem ; 78(8): 3592-615, 2013 Apr 19.
Article in English | MEDLINE | ID: mdl-23544787

ABSTRACT

The development of zinc-mediated and -catalyzed asymmetric propargylations of trifluoromethyl ketones with a propargyl borolane and the N-isopropyl-l-proline ligand is presented. The methodology provided moderate to high stereoselectivity and was successfully applied on a multikilogram scale for the synthesis of the Glucocorticoid agonist BI 653048. A mechanism for the boron-zinc exchange with a propargyl borolane is proposed and supported by modeling at the density functional level of theory. A water acceleration effect on the zinc-catalyzed propargylation was discovered, which enabled a catalytic process to be achieved. Reaction progress analysis supports a predominately rate limiting exchange for the zinc-catalyzed propargylation. A catalytic amount of water is proposed to generate an intermediate that catalyzes the exchange, thereby facilitating the reaction with trifluoromethyl ketones.


Subject(s)
Boronic Acids/chemistry , Hydrocarbons, Fluorinated/chemistry , Ketones/chemistry , Pargyline/analogs & derivatives , Pargyline/chemistry , Proline/analogs & derivatives , Proline/chemistry , Zinc/chemistry , Catalysis , Molecular Structure , Stereoisomerism
6.
Ear Hear ; 27(5): 550-62, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16957504

ABSTRACT

OBJECTIVE: A series of experiments designed to test the preferences of people with moderate to profound hearing losses for limiting the output of hearing aids by using peak clipping (PC), fast compression limiting (FCL), PC and FCL, and these three methods in combination with slow compression limiting (SCL) was conducted. DESIGN: Nineteen participants with moderate to profound sensorineural or mixed losses were recruited. In the first experiment, preferences for either PC or FCL were tested in a field trial in the participants' usual environments.A second experiment examined the acceptance of PC, FCL, and FCL + PC, using paired comparisons in a laboratory setting. The third experiment involved further paired comparisons in the laboratory to evaluate whether participants preferred PC, FCL, PC and FCL combined, or the three methods when combined with SCL. RESULTS: The participants showed no statistically significant preferences for either peak clipping or fast compression limiting in the field trial. In the laboratory trial, both FCL + PC and FCL were significantly preferred over PC alone, and the addition of FCL to PC was most advantageous to participants who required the lowest maximum limiting output. The most dramatic laboratory result was the convincing preference in paired comparison testing of combining SCL with PC and/or FCL. CONCLUSIONS: Slow compression limiting appears to be a desirable feature in hearing aids for clients with a moderate to profound hearing loss. Preferences were not as pronounced when peak clipping, fast compression limiting, and peak clipping plus fast compression limiting were compared, but participants favored the condition that had the least amount of peak clipping.


Subject(s)
Consumer Behavior , Hearing Aids , Hearing Loss, Mixed Conductive-Sensorineural/rehabilitation , Hearing Loss, Sensorineural/rehabilitation , Loudness Perception/physiology , Adult , Aged , Choice Behavior , Equipment Design , Female , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...